163 related articles for article (PubMed ID: 36791751)
1. Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice.
Jamieson A; McAlpine JN
J Natl Compr Canc Netw; 2023 Feb; 21(2):210-216. PubMed ID: 36791751
[TBL] [Abstract][Full Text] [Related]
2. Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape.
Jamieson A; Barroilhet LM; McAlpine JN
Cancer; 2022 Aug; 128(15):2853-2857. PubMed ID: 35657171
[TBL] [Abstract][Full Text] [Related]
3. Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification.
Jamieson A; Huvila J; Thompson EF; Leung S; Chiu D; Lum A; McConechy M; Grondin K; Aguirre-Hernandez R; Salvador S; Kean S; Samouelian V; Gougeon F; Azordegan N; Lytwyn A; Parra-Herran C; Offman S; Gotlieb W; Irving J; Kinloch M; Helpman L; Scott SA; Vicus D; Plante M; Huntsman DG; Gilks CB; Talhouk A; McAlpine JN
Gynecol Oncol; 2022 May; 165(2):201-214. PubMed ID: 35246332
[TBL] [Abstract][Full Text] [Related]
4. Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer.
Yen TT; Wang TL; Fader AN; Shih IM; Gaillard S
Int J Gynecol Pathol; 2020 Jan; 39(1):26-35. PubMed ID: 30741844
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of molecular characteristics into endometrial cancer management.
Vermij L; Smit V; Nout R; Bosse T
Histopathology; 2020 Jan; 76(1):52-63. PubMed ID: 31846532
[TBL] [Abstract][Full Text] [Related]
6. Treatment strategies for endometrial cancer: current practice and perspective.
Lee YC; Lheureux S; Oza AM
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):47-58. PubMed ID: 27941361
[TBL] [Abstract][Full Text] [Related]
7. Molecular testing for endometrial cancer: An SGO clinical practice statement.
Walsh CS; Hacker KE; Secord AA; DeLair DF; McCourt C; Urban R
Gynecol Oncol; 2023 Jan; 168():48-55. PubMed ID: 36399812
[TBL] [Abstract][Full Text] [Related]
8. Moving into the modern era of molecular classification for endometrial cancer.
Dagher C; Liu YL; Mueller JJ; Weigelt B
J Surg Oncol; 2024 Jan; 129(1):120-125. PubMed ID: 38100711
[TBL] [Abstract][Full Text] [Related]
9. Endometrial cancer: molecular and therapeutic aspects.
Tsikouras P; Bouchlariotou S; Vrachnis N; Dafopoulos A; Galazios G; Csorba R; von Tempelhoff GF
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):1-9. PubMed ID: 23433742
[TBL] [Abstract][Full Text] [Related]
10. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Talhouk A; McConechy MK; Leung S; Yang W; Lum A; Senz J; Boyd N; Pike J; Anglesio M; Kwon JS; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Cancer; 2017 Mar; 123(5):802-813. PubMed ID: 28061006
[TBL] [Abstract][Full Text] [Related]
11. Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and Proactive Molecular Risk Classifier for Endometrial Cancer classifier.
Huvila J; Orte K; Vainio P; Mettälä T; Joutsiniemi T; Hietanen S
Hum Pathol; 2021 May; 111():98-109. PubMed ID: 33662372
[TBL] [Abstract][Full Text] [Related]
12. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
13. Identification of
Beinse G; Rance B; Just PA; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Batteux F; Durdux C; Chapron C; Pasmant E; Leroy K; Alexandre J; Borghese B
Int J Gynecol Cancer; 2020 May; 30(5):640-647. PubMed ID: 32169874
[TBL] [Abstract][Full Text] [Related]
14. High-grade endometrial carcinomas: Morphologic spectrum and molecular classification.
Zhang C; Zheng W
Semin Diagn Pathol; 2022 May; 39(3):176-186. PubMed ID: 34852949
[TBL] [Abstract][Full Text] [Related]
15. A clinically applicable molecular-based classification for endometrial cancers.
Talhouk A; McConechy MK; Leung S; Li-Chang HH; Kwon JS; Melnyk N; Yang W; Senz J; Boyd N; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Br J Cancer; 2015 Jul; 113(2):299-310. PubMed ID: 26172027
[TBL] [Abstract][Full Text] [Related]
16. [The influence of molecular classification in the selection of postoperative adjuvant therapy in endometrial carcinoma].
Yan XS; Li M; Liang HM; Guo HY; Wu Y; He HJ; Zhang K; Li H
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(32):2500-2505. PubMed ID: 36008320
[No Abstract] [Full Text] [Related]
17. Endometrial cancer: Not your grandmother's cancer.
McAlpine JN; Temkin SM; Mackay HJ
Cancer; 2016 Sep; 122(18):2787-98. PubMed ID: 27308732
[TBL] [Abstract][Full Text] [Related]
18. High-Grade Endometrial Carcinomas: Classification with Molecular Insights.
Carlson JW; Nastic D
Surg Pathol Clin; 2019 Jun; 12(2):343-362. PubMed ID: 31097108
[TBL] [Abstract][Full Text] [Related]
19. High risk endometrial cancer: Clues towards a revision of the therapeutic paradigm.
Bendifallah S; Ilenko A; Daraï E
J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):863-871. PubMed ID: 31176047
[TBL] [Abstract][Full Text] [Related]
20. Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer.
Soumerai TE; Donoghue MTA; Bandlamudi C; Srinivasan P; Chang MT; Zamarin D; Cadoo KA; Grisham RN; O'Cearbhaill RE; Tew WP; Konner JA; Hensley ML; Makker V; Sabbatini P; Spriggs DR; Troso-Sandoval TA; Charen AS; Friedman C; Gorsky M; Schweber SJ; Middha S; Murali R; Chiang S; Park KJ; Soslow RA; Ladanyi M; Li BT; Mueller J; Weigelt B; Zehir A; Berger MF; Abu-Rustum NR; Aghajanian C; DeLair DF; Solit DB; Taylor BS; Hyman DM
Clin Cancer Res; 2018 Dec; 24(23):5939-5947. PubMed ID: 30068706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]